Gemfibrozil-trans-cinnamic acid co-crystal: Synthesis, characterization, in vitro solubility and cell viability studies

1Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

The co-crystallization is a technic used to improve drug properties, mainly for drugs belonging to classes II and IV of the Biopharmaceutical Classification System like gemfibrozil (GEM). This study aims to synthesize a new co-crystal of GEM and trans-cinnamic acid (TCA) through the mechanochemistry method, characterize it using powder X-ray diffraction, Fourier-transform infrared spectroscopy, differential scanning calorimetry, and thermogravimetric analysis, and determine the equilibrium solubility and cytotoxicity of the new crystalline form. The characterization techniques indicated that the cocrystal was successfully formed, especially because they revealed a unique X-ray pattern and a single endothermic event, different from the isolated substances. The concomitant use of GEM and TCA was shown to be safe at concentrations up to 100 M in models using Caco-2 cells. The formation of the GEM: TCA co-crystal was successful, and the new co-crystal was not cytotoxic at the concentrations analyzed.

Cite

CITATION STYLE

APA

Silva, J. R. A., da Cunha Holanda, B. B., de Souza e Silva, G. T., Moraes, C. R. P., Barbosa, T. W. L., dos Santos, É. M., … Rosa, P. C. P. (2023). Gemfibrozil-trans-cinnamic acid co-crystal: Synthesis, characterization, in vitro solubility and cell viability studies. Journal of Applied Pharmaceutical Science, 13(9), 18–26. https://doi.org/10.7324/JAPS.2023.93828

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free